cancers-logo

Journal Browser

Journal Browser

Thoracic Surgical Oncology—Current Landscape and Future Directions

A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Clinical Research of Cancer".

Deadline for manuscript submissions: 31 January 2027 | Viewed by 147

Special Issue Editors


E-Mail Website1 Website2
Guest Editor
Division of Thoracic Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
Interests: lung cancer; mediastinal tumour; thymic neoplasms; minimally invasive surgery; robotic surgery; lung metastases; chest wall surgery
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Thoracic Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
Interests: lung cancer; mediastinal tumour; thymic neoplasms; minimally invasive surgery; lung metastases; chest wall surgery; paediatric thoracic surgery

Special Issue Information

Dear Colleagues,

Thoracic surgical oncology stands at a transformative stage where technological innovation is beginning to be associated with evolving systemic treatments.

The integration of minimally invasive techniques and advanced diagnostic tools is fundamentally reengineering the concept of surgical precision. As perioperative immunotherapy and targeted therapies profoundly reshape treatment algorithms, across lung, oesophageal, and mediastinal malignancies, we also observe the challenge of increasingly complex procedures. These include advanced bronchial and vascular reconstructions, rescue surgery after the failure of complex multimodality therapies and oligometastatic disease, together with novel strategies such as intrathoracic chemoperfusion or surgery under ECMO support. These advances in surgical intervention represent the future of our discipline and are further enhanced by the emergence of liquid biopsy technology for minimal residual disease detection, offering unprecedented opportunities for dynamic risk stratification and personalized treatment adaptation throughout the patient's therapeutic journey.

This Special Issue addresses pivotal controversies and cutting-edge developments spanning oesophageal cancer, mesothelioma, thymic tumours, oligometastatic disease, and innovative diagnostic technologies.

Through systematic reviews, original articles, and comprehensive reviews, we provide comprehensive insight into contemporary thoracic oncology.

Dr. Piergiorgio Solli
Dr. Alessia Stanzi
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • minimally invasive thoracic surgery
  • immunotherapy
  • liquid biopsy
  • lung cancer
  • mesothelioma
  • esophageal cancer
  • precision oncology

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop